AVAI Bio, Inc. (AVAI) stock
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
$0.11−0.00 (-1.75%)
Close on Oct 19, 2026Market cap $17.24MP/E –Yield –
AVAI Bio operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
AVAI Bio's operating income for the twelve months ending Jun 30, 2026 was -$1.81M. For fiscal 2026 it was -$1.75M. The highest annual figure on record is $302.29K in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$1.75M | – |
| FY2025 | Mar 31, 2025 | -$1.14M | – |
| FY2024 | Mar 31, 2024 | -$2.13M | – |
| FY2023 | Mar 31, 2023 | -$348.93K | -375.8% |
| FY2022 | Mar 31, 2022 | $126.52K | -58.1% |
| FY2021 | Mar 31, 2021 | $302.29K | +334.4% |
| FY2020 | Mar 31, 2020 | $69.59K | – |
| FY2019 | Mar 31, 2019 | -$78.23K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$552.04K | -213.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$255.18K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$553.73K | -222.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$453.02K | -172.7% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $487.59K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$2.75M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $452.30K | -55.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $623.05K | +55.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$528.84K | -228.5% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$3.95M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $1.01M | +817.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $399.62K | +377.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $411.52K | +1282.7% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$572.93K | -8058.4% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $110.47K | -68.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $83.76K | -49.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $29.76K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $7.20K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $349.33K | -16.3% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $166.32K | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$396.33K | -914.1% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$15.73K | -110.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $417.16K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$50.46K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $48.68K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $152.64K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$26.70K | – |
See a number that looks wrong?